New feeding tube method may help tracheotomy patients swallow again and remove breathing tube sooner
NCT ID NCT06791590
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study compares two ways of feeding patients who have a tracheotomy (a tube in the windpipe) and swallowing problems caused by nerve damage. One method uses a tube placed through the mouth into the esophagus (intermittent oro-esophageal, or IOE), while the other uses a tube through the nose into the intestine. The main goal is to see which method helps patients remove their tracheotomy tube faster and improves swallowing safety. The trial enrolls 140 adults whose acute illness has passed and who are ready to start the decannulation process.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- intermittent oro-esophageal tube feeding (IOE)
- What this could lead to
- If IOE proves better, it could become a standard nutrition method that helps tracheotomy patients with swallowing problems remove their breathing tube faster and improve quality of life.
- What could go wrong
- This is a single-center study with 140 participants, so results may not apply broadly. IOE requires patient cooperation and may not be suitable for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
140 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 92 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of neurogenic dysphagia； * Acute phase has passed, weaning time \> 48 hours, tracheotomy time \>1 week; in accordance with the decannulation process of tracheotomy patients formulated by our center in 2018; * steady vital signs, without severe cognitive impairment or sensory aphasia, able to cooperate with the assessment； * Gastrointestinal motility is good, can tolerate more than 150ml/h feeding pump speed; * Willing to sign an informed consent form. Exclusion Criteria: * Structural swallowing disorders, such as oral, pharyngeal, larynx, esophagus and other anatomical abnormalities caused by swallowing disorders; * The clinical condition was unstable, accompanied by heart, lung, brain and other important organ dysfunction; * Severe cognitive dysfunction, confusion, unable to cooperate.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neurogenic dysphagia are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Rehabilitation Hospital, Capital Medical University
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.